Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study

This is the authors' abstract. We don't add key points for this paper.

For the treatment of FN patients either colonized with ESBL-E or having significant risk factors for ESBL-E infection, aminoglycoside containing combinations may become an alternative to carbapenems due to their high sensitivity rates. When CRE colonized hematological cancer patients develop FN or if they are hemodynamically unstable, CRE covering empiric antibiotherapy should be preferred due to high mortality rates of CRE bacteremia.